Table II. Neoadjuvant therapy and surgical characteristics of patients (n=84).
CDDP: Cisplatin; DOC: docetaxel; 5-FU: 5-fluorouracil; NDP: nedaplatin; RECIST: Response Evaluation Criteria in Solid Tumors (9). *Clavien-Dindo classification.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.